Allurion Technologies shares soared 200% Friday as it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see if the combination improves patients' muscle mass.

Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI ...

Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to ...

Allurion Technologies announced it would begin a study to see if its gastric balloon, combined with popular GLP-1 medicines like Novo Nordisk's Wegovy, could improve muscle mass and overall body ...

The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less TM gastric balloon for weight loss, the Allurion ...

In contrast, patients treated with the Allurion Balloon and Allurion Virtual Care Suite have not only lost weight but have also maintained or even gained lean body mass. The CEO of Allurion ...

In contrast, patients treated with the Allurion Balloon and Allurion Virtual Care Suite have not only lost weight but have also maintained or even gained lean body mass. The CEO of Allurion, Dr.